• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Tomida Akimasa  富田 晃正

ORCIDConnect your ORCID iD *help
… Alternative Names

富田 晃正  トミダ アキマサ

Less
Researcher Number 30933022
Other IDs
Affiliation (Current) 2025: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Affiliation (based on the past Project Information) *help 2022 – 2023: 京都府立医科大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field
Principal Investigator
Basic Section 54010:Hematology and medical oncology-related
Except Principal Investigator
Basic Section 52050:Embryonic medicine and pediatrics-related
Keywords
Principal Investigator
免疫疲弊 / 固形腫瘍 / 神経芽腫 / 小児がん / 腫瘍微小環境 / 併用療法 / 分子標的薬 / CAR-T細胞
Except Principal Investigator
小児固形腫瘍 / WT1 / 腫瘍溶解性アデノウイルス
  • Research Projects

    (2 results)
  • Research Products

    (2 results)
  • Co-Researchers

    (3 People)
  •  Novel therapeutic strategy for pediatric malignant solid tumors using WT1 promoter-regulated oncovirus

    • Principal Investigator
      吉田 秀樹
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 52050:Embryonic medicine and pediatrics-related
    • Research Institution
      Kyoto Prefectural University of Medicine
  •  Development of CAR-T cell therapy combined with molecular-targeted drugs to avoid immune exhaustionPrincipal Investigator

    • Principal Investigator
      富田 晃正
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      Kyoto Prefectural University of Medicine

All 2023 2022

All Presentation

  • [Presentation] Immunomodulatory effect of the MEK pathway inhibitor enhanced the efficacy of GD2-CAR-T cell therapy against neuroblastoma2023

    • Author(s)
      Tomida Akimasa, Yagyu Shigeki, Kubo Hiroshi, Nakazawa Yozo, Hosoi Hajime, Iehara Tomoko
    • Organizer
      Advances in Neuroblastoma Research (ANR) meeting 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K16328
  • [Presentation] MEK阻害剤は神経芽腫に対するGD2特異的CAR-T細胞療法の抗腫瘍効果を高める2022

    • Author(s)
      富田晃正、柳生茂希、久保裕、中沢洋三、細井創、家原知子
    • Organizer
      第60回日本癌治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K16328
  • 1.  吉田 秀樹 (10643546)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  菊地 顕 (40453104)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  宮地 充 (40584983)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi